Golden has been acquired by ComplyAdvantage.Read about it here ⟶

List of SBIR/STTR awards granted to ArmaGen Technologies

where

SBIR/STTR Award Recipient

‌

ArmaGen Technologies

Name	Description	SBIR/STTR Award Recipient	Award Type	Contract Number (US Government)	Award Phase	Award Amount (USD)	Date Awarded	Official Website
‌ ARMAGEN TECHNOLOGIES, INC. SBIR Phase II Award, April 2015	A SBIR Phase II contract was awarded to ArmaGen Technologies in April, 2015 for $1,033,433.0 USD from the U.S. Department of Health & Human Services.	‌ ArmaGen Technologies	SBIR	2R44NS088868-02	Phase II	1,033,433	April 1, 2015	sbir.gov/node/1048857
‌ ARMAGEN TECHNOLOGIES, INC. SBIR Phase II Award,	A SBIR Phase II contract was awarded to ArmaGen Technologies for $1,052,435.0 USD from the U.S. Department of Health & Human Services.	‌ ArmaGen Technologies	SBIR	2R44NS067707-02	Phase II	1,052,435		sbir.gov/node/389421
‌ ARMAGEN TECHNOLOGIES, INC. SBIR Phase II Award,	A SBIR Phase II contract was awarded to ArmaGen Technologies for $999,645.0 USD from the U.S. Department of Health & Human Services.	‌ ArmaGen Technologies	SBIR	2R44HD074272-02	Phase II	999,645		sbir.gov/node/678816
‌ ARMAGEN TECHNOLOGIES, INC. SBIR Phase II Award,	A SBIR Phase II contract was awarded to ArmaGen Technologies for $981,134.0 USD from the U.S. Department of Health & Human Services.	‌ ArmaGen Technologies	SBIR	2R44AG042181-02	Phase II	981,134		sbir.gov/node/678530
‌ ARMAGEN TECHNOLOGIES, INC. SBIR Phase I Award,	A SBIR Phase I contract was awarded to ArmaGen Technologies for $112,000.0 USD from the U.S. Department of Health & Human Services.	‌ ArmaGen Technologies	SBIR	1R43AG020876-01	Phase I	112,000		sbir.gov/content/drug-development-alzheimers-disease-brain-scan-0
‌ ARMAGEN TECHNOLOGIES, INC. SBIR Phase I Award,	A SBIR Phase I contract was awarded to ArmaGen Technologies for $149,050.0 USD from the U.S. Department of Health & Human Services.	‌ ArmaGen Technologies	SBIR	1R43MH083334-01	Phase I	149,050		sbir.gov/content/bioengineering-new-antibody-drug-delivery-technology-0
‌ ARMAGEN TECHNOLOGIES, INC. SBIR Phase I Award,	A SBIR Phase I contract was awarded to ArmaGen Technologies for $100,000.0 USD from the U.S. Department of Health & Human Services.	‌ ArmaGen Technologies	SBIR	1R43NS051076-01	Phase I	100,000		sbir.gov/content/neuroprotection-stroke-w-recombinant-fusion-protein-0
‌ ARMAGEN TECHNOLOGIES, INC. SBIR Phase II Award,	A SBIR Phase II contract was awarded to ArmaGen Technologies for $1,358,735.0 USD from the U.S. Department of Health & Human Services.	‌ ArmaGen Technologies	SBIR	2R44AG020876-02	Phase II	1,358,735		sbir.gov/content/drug-development-alzheimers-disease-brain-scan-2
‌ ARMAGEN TECHNOLOGIES, INC. SBIR Phase I Award,	A SBIR Phase I contract was awarded to ArmaGen Technologies for $111,999.0 USD from the U.S. Department of Health & Human Services.	‌ ArmaGen Technologies	SBIR	1R43NS066514-01	Phase I	111,999		sbir.gov/content/bioengineering-new-decoy-receptor-drug-delivery-technology-0
‌ ARMAGEN TECHNOLOGIES, INC. SBIR Phase I Award,	A SBIR Phase I contract was awarded to ArmaGen Technologies for $100,000.0 USD from the U.S. Department of Health & Human Services.	‌ ArmaGen Technologies	SBIR	1R43HD052303-01	Phase I	100,000		sbir.gov/content/recombinant-enzyme-fusion-protein-lysosomal-storage-0
‌ ARMAGEN TECHNOLOGIES, INC. SBIR Phase I Award,	A SBIR Phase I contract was awarded to ArmaGen Technologies for $385,780.0 USD from the U.S. Department of Health & Human Services.	‌ ArmaGen Technologies	SBIR	1R43NS062458-01A1	Phase I	385,780		sbir.gov/content/targeted-delivery-sirna-intravenous-rnai-0
‌ ARMAGEN TECHNOLOGIES, INC. SBIR Phase II Award,	A SBIR Phase II contract was awarded to ArmaGen Technologies for $749,152.0 USD from the U.S. Department of Health & Human Services.	‌ ArmaGen Technologies	SBIR	2R44NS051076-02A1	Phase II	749,152		sbir.gov/content/stroke-neuroprotection-recombinant-fusion-protein-0
‌ ARMAGEN TECHNOLOGIES, INC. SBIR Phase I Award,	A SBIR Phase I contract was awarded to ArmaGen Technologies for $589,796.0 USD from the U.S. Department of Health & Human Services.	‌ ArmaGen Technologies	SBIR	1R43CA109782-01	Phase I	589,796		sbir.gov/content/targeted-egfr-antisense-gene-therapy-brain-cancer-0
‌ ARMAGEN TECHNOLOGIES, INC. SBIR Phase II Award,	A SBIR Phase II contract was awarded to ArmaGen Technologies for $2,940,848.0 USD from the U.S. Department of Health & Human Services.	‌ ArmaGen Technologies	SBIR	2U44NS064602-01	Phase II	2,940,848		sbir.gov/content/iduronidase-replacement-therapy-brain-hurlers-syndrome-2
‌ ARMAGEN TECHNOLOGIES, INC. SBIR Phase I Award,	A SBIR Phase I contract was awarded to ArmaGen Technologies for $111,214.0 USD from the U.S. Department of Health & Human Services.	‌ ArmaGen Technologies	SBIR	1R43NS067707-01A1	Phase I	111,214		sbir.gov/node/368969
‌ ARMAGEN TECHNOLOGIES, INC. SBIR Phase I Award,	A SBIR Phase I contract was awarded to ArmaGen Technologies for $100,000.0 USD from the U.S. Department of Health & Human Services.	‌ ArmaGen Technologies	SBIR	1R43NS044654-01A1	Phase I	100,000		sbir.gov/content/neuroprotection-stroke-drug-development-0
‌ ARMAGEN TECHNOLOGIES, INC. SBIR Phase II Award,	A SBIR Phase II contract was awarded to ArmaGen Technologies for $3,727,390.0 USD from the U.S. Department of Health & Human Services.	‌ ArmaGen Technologies	SBIR	2R44NS044654-05	Phase II	3,727,390		sbir.gov/content/neuroprotection-stroke-drug-development-2
‌ ARMAGEN TECHNOLOGIES, INC. SBIR Phase I Award,	A SBIR Phase I contract was awarded to ArmaGen Technologies for $100,000.0 USD from the U.S. Department of Health & Human Services.	‌ ArmaGen Technologies	SBIR	1R43HD057631-01	Phase I	100,000		sbir.gov/content/iduronidase-replacement-therapy-brain-hurlers-syndrome-0
‌ ARMAGEN TECHNOLOGIES, INC. SBIR Phase I Award,	A SBIR Phase I contract was awarded to ArmaGen Technologies for $1,951,120.0 USD from the U.S. Department of Health & Human Services.	‌ ArmaGen Technologies	SBIR	1U44NS057843-01	Phase I	1,951,120		sbir.gov/content/targeted-paraoxonase-fusion-protein-neurotherapeutic-nerve-gas-agents-0
‌ ARMAGEN TECHNOLOGIES, INC. SBIR Phase I Award,	A SBIR Phase I contract was awarded to ArmaGen Technologies for $156,555.0 USD from the U.S. Department of Health & Human Services.	‌ ArmaGen Technologies	SBIR	1R43HD074272-01	Phase I	156,555		sbir.gov/node/400654
‌ ARMAGEN TECHNOLOGIES, INC. SBIR Phase I Award,	A SBIR Phase I contract was awarded to ArmaGen Technologies for $100,000.0 USD from the U.S. Department of Health & Human Services.	‌ ArmaGen Technologies	SBIR	1R43NS051857-01	Phase I	100,000		sbir.gov/content/imaging-brain-amyloid-bispecific-antibody-0
‌ ARMAGEN TECHNOLOGIES, INC. SBIR Phase II Award,	A SBIR Phase II contract was awarded to ArmaGen Technologies for $849,582.0 USD from the U.S. Department of Health & Human Services.	‌ ArmaGen Technologies	SBIR	2R44MH083334-02	Phase II	849,582		sbir.gov/content/bioengineering-new-antibody-drug-delivery-technology-1
‌ ARMAGEN TECHNOLOGIES, INC. SBIR Phase I Award,	A SBIR Phase I contract was awarded to ArmaGen Technologies for $148,530.0 USD from the U.S. Department of Health & Human Services.	‌ ArmaGen Technologies	SBIR	1R43AG042181-01	Phase I	148,530		sbir.gov/node/399528
‌ ARMAGEN TECHNOLOGIES, INC. SBIR Phase I Award,	A SBIR Phase I contract was awarded to ArmaGen Technologies for $149,800.0 USD from the U.S. Department of Health & Human Services.	‌ ArmaGen Technologies	SBIR	1R43NS074539-01	Phase I	149,800		sbir.gov/node/369013
‌ ARMAGEN TECHNOLOGIES, INC. SBIR Phase I Award,	A SBIR Phase I contract was awarded to ArmaGen Technologies for $152,138.0 USD from the U.S. Department of Health & Human Services.	‌ ArmaGen Technologies	SBIR	1R43NS088868-01	Phase I	152,138		sbir.gov/node/706317

Results per page:

27 results

0 selected

27 results

0 selected